Inspiring transformational change in the

field of oncology diagnostics


To develop and deliver accurate, rapid, minimally

invasive oncology diagnostic products utilising our

patented MCM5 antibodies

Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.



MCM Technology


Latest News

Arquer Diagnostics @Arquer Diagnostics
If you're growing a moustache for Movember, don't forget to spread awareness and raise money for men's health. Prostate and testicular cancer can be treated if diagnosed early. Find out more, here: #Arquer #ArquerDiagnostics #medical #diagnostics

- 23 hours ago

Arquer Diagnostics @Arquer Diagnostics
"Arquer CEO Nadia Whittley Named Among Top 50 Female "Movers & Shakers" in BioBusiness Report" - the 5th annual report, compiled by BioBeat, identifies women who are developing revolutionary bioscience products for healthcare @BioBeatUK -

- 12 days ago

Arquer Diagnostics @Arquer Diagnostics
Prior to now, it was unclear whether treating advanced #prostatecancer with standard treatment plus radiotherapy had any benefit. However, a new study saw an 11% increase in survival rates in some patients. Find out more here - #Arquer #cancer #health

- 15 days ago

1 2
Arquer Diagnostics @Arquer Diagnostics
RT @TUF_tweets: It may be the end of October, but here's three reasons why it's time you stopped smoking.

- 15 days ago

Arquer Diagnostics @Arquer Diagnostics
Did you know that fewer than 1% of avocados tested positive for pesticides, which have a high chance of causing #cancer in humans, this year. In fact, a new study proves that eating organically can significantly reduce your cancer risk - #Arquer #organic

- 16 days ago